Meeder Asset Management’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,210
Closed -$79.5K 956
2024
Q3
$79.5K Hold
15,210
0.01% 314
2024
Q2
$67.8K Buy
+15,210
New +$67.8K ﹤0.01% 307